The Global “Gene Therapy market” was valued at $393.35 million in 2018, and is estimated to reach $6,205.85 million by 2026, registering a CAGR of 34.8% from 2019 to 2026.
Get PDF Sample Copy of the “Gene Therapy Market” Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ www.marketgrowthinsight.com/sample/72026
Gene therapy is largely motivated by the promise of CAR T-cell use that has gained significant interest as a new business model from both commercial and non-commercial sponsors. Gene therapy accounts for a large share of the pipeline in the pharmaceutical industry, and this is expected to continue as drugs will become commercially available in the R&D process in the coming years.
The global gene therapy market is segmented based on vector type, gene type, application, and geography. Based on vector type, it is categorized into viral vector and non-viral vector. Viral vector is further segmented into retroviruses, lentiviruses, adenoviruses, adeno associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others. Non-viral vector is further categorized into naked/plasmid vectors, gene gun, electroporation, lipofection, and others. Based on gene type, the market is classified into antigen, cytokine, tumor suppressor, suicide, deficiency, growth factors, receptors, and others. Based on application, the market is divided into oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and other diseases. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major Players Covered in this Report are:
Adaptimmune Therapeutics Plc., Anchiano Therapeutics Ltd., Achieve Life Sciences Inc., Adverum Biotechnologies Inc., Abeona Therapeutics Inc., Applied Genetic Technologies Corporation, Arbutus Biopharma Corporation, Audentes Therapeutics Inc., AveXis Inc., Bluebird Bio Inc., Celgene Corporation, CRISPR Therapeutics AG, Editas Medicine Inc., Editas Medicine Inc., GlaxoSmithKline Plc., Intellia Therapeutics Inc., Merck & Co. Inc., Novartis AG, REGENXBIO Inc., Spark Therapeutics Inc., Sangamo Therapeutics Inc., Uniqure N. V.
The updated market research report on Gene Therapy market allows the buyers and manufacturers to stay updated with the current market trends, ongoing happenings, and a clear picture on the market scenario. List of key players included in the research report will help the market vendors to know their market position and plan more operational strategies to gain topmost position among other players. The report offers crucial company information on each market player, such as company profile, financial information, and recently adopted growth strategies. This will help other existing players and the new entrants to plan strategies and establish their presence in the market.
The report is divided into major categories comprising product, distribution channel, application, and end users. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Every segment is studied thoroughly in order to offer a better picture to the buyers and stakeholders to benefit from. Information like highest prevailing product, highly demanded product by the application segment and end users are rightly mentioned in the Gene Therapy report.
By Gene Type
• Tumor Suppressor
• Growth factors
• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious disease
• Other Diseases
The report answers important questions that companies may have when operating in the global Gene Therapy market. Some of the questions are given below:
• What will be the size of the global Gene Therapy market in 2025?
• What is the current CAGR of the global Gene Therapy market?
• Which product is expected to show the highest market growth?
• Which application is projected to gain a lion’s share of the global Gene Therapy market?
• Which region is foretold to create the most number of opportunities in the global Gene Therapy market?
• Will there be any changes in market competition during the forecast period?
• Which are the top players currently operating in the global Gene Therapy market?
Table of Content:
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Gene Therapy Market, By Vector Type
Chapter 5: Gene Therapy Market, By Gene Type
Chapter 6: Gene Therapy Market, By Application
Chapter 7: Gene Therapy Market, By Region
Chapter 8: Company Profile
If You Have Any Query, Ask Our Experts @ www.marketgrowthinsight.com/inquiry/72026
Market Growth Insight 100% Subsidiary of Exltech Solutions India, is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 30000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends.
This release was published on openPR.